People taking popular new weight-loss drugs such as Wegovy and Zepbound often celebrate the number of pounds they shed and ...

The obesity rate for adults in the U.S. dropped to 37% in 2025 after peaking at 39.9% in 2022, but diabetes has reached an ...

Groundbreaking GLP-1 drugs like Ozempic, Mounjaro and Wegovy are revolutionising weight loss, with studies showing ...

Ozempic, Mounjaro and Wegovy are now cultural symbols of weight loss. These medications help control blood sugar and aid ...

This article was reviewed by Darragh O’Carroll, MD. Long-Term Side Effects of Wegovy® Key takeaways: The long-term side ...

A trial funded by the Labour Government will ensure obese Scots have free access to Wegovy medication that can cost over £100 ...

The FDA-approved medications for weight loss and diabetes remain a life-changing therapy in many countries, and for some individuals, it is an affordable luxury. Let's delve deep into how prices vary ...

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...

NHS Lothian spent over £1m on weight loss drugs in 2024/25 alone amid rising prescription demand and national obesity concerns.

A woman has taken to the internet to share the biggest difference she experienced when switching between GLP-1 drugs Wegovy ...

It might sound shocking to read about such drastic actions, but it’s stories of overweight children being bullied and too ...

Wegovy Zepbound cost-effectiveness report finds both drugs remain valuable at higher prices despite affordability concerns, per ICER analysis.